-
LXEO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Lexeo Therapeutics, Inc. Common Stock (LXEO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 160.27 mm | 160.27 mm | 160.27 mm | 160.27 mm | 160.27 mm | 160.27 mm |
Cash burn (monthly) | 5.99 mm | (no burn) | 10.51 mm | 7.78 mm | 176.00 k | 1.37 mm |
Cash used (since last report) | 24.13 mm | n/a | 42.37 mm | 31.35 mm | 709.28 k | 5.52 mm |
Cash remaining | 136.14 mm | n/a | 117.90 mm | 128.92 mm | 159.56 mm | 154.75 mm |
Runway (months of cash) | 22.7 | n/a | 11.2 | 16.6 | 906.6 | 113.0 |
13F holders | Current |
---|---|
Total holders | 73 |
Opened positions | 17 |
Closed positions | 6 |
Increased positions | 37 |
Reduced positions | 10 |
13F shares | Current |
---|---|
Total value | 268.38 bn |
Total shares | 38.20 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
JHG Janus Henderson | 3.76 mm | $34.00 bn |
Longitude Capital Partners IV | 2.77 mm | $22.90 mm |
Citadel Advisors | 2.72 mm | $24.62 bn |
Adage Capital Partners GP, L.L.C. | 2.60 mm | $23.48 bn |
Adage Capital Management | 2.60 mm | $21.51 mm |
D1 Capital Partners | 2.51 mm | $22.66 bn |
Omega Fund Management | 2.36 mm | $21.30 bn |
Omega Fund VI | 2.16 mm | $36.31 mm |
Eventide Asset Managment | 1.86 mm | $16.78 bn |
BlackRock | 1.63 mm | $14.74 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | Kyle Rasbach | Common Stock | Grant | Acquire A | No | No | 0 | 40,875 | 0.00 | 40,875 |
17 Jan 25 | Kyle Rasbach | Stock Option Common Stock | Grant | Acquire A | No | No | 5.07 | 245,250 | 1.24 mm | 245,250 |
7 Jan 25 | Jose Manuel Otero | Common Stock | Grant | Acquire A | No | No | 0 | 26,250 | 0.00 | 57,500 |
7 Jan 25 | Jose Manuel Otero | Stock Option Common Stock | Grant | Acquire A | No | No | 7.33 | 52,500 | 384.83 k | 52,500 |
7 Jan 25 | Jenny Robertson | Common Stock | Grant | Acquire A | No | No | 0 | 36,250 | 0.00 | 60,000 |
7 Jan 25 | Jenny Robertson | Stock Option Common Stock | Grant | Acquire A | No | No | 7.33 | 72,500 | 531.42 k | 72,500 |
7 Jan 25 | Tai Sandi See | Common Stock | Grant | Acquire A | No | No | 0 | 38,750 | 0.00 | 55,375 |
7 Jan 25 | Tai Sandi See | Stock Option Common Stock | Grant | Acquire A | No | No | 7.33 | 77,500 | 568.08 k | 77,500 |
7 Jan 25 | Richard Nolan Townsend | Common Stock | Grant | Acquire A | No | No | 0 | 103,750 | 0.00 | 224,445 |
7 Jan 25 | Richard Nolan Townsend | Stock Option Common Stock | Grant | Acquire A | No | No | 7.33 | 207,500 | 1.52 mm | 207,500 |